Octant is engineering a new generation of drug discovery.

Octant is developing a multiplexed technology that uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells, paving the way for a new modality for drug discovery.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2017

• Founders

  • Sri Kosuri
  • Ramsey Homsany

  LUX Partners

  • Adam Goulburn

• Latest Tweets

  • We’re celebrating our SynBio Apprentices today. Excited to host Chef Elmy at the lab. He’s an East Bay institution. https://t.co/EzlOZTgVnh@OctantBio - 02:44 PM May 21st
  • Among so many things, @GabbyCW makes sure that Octant has what it needs to keep our polypharmacology discovery engi… https://t.co/OGC18js74z@OctantBio - 09:54 PM Apr 28th
  • "This is the year the promise of synthetic biology in healthcare finally arrived." Read more 'Reflections on Movin… https://t.co/9RljJW2lGG@OctantBio - 03:30 PM Apr 21st